Literature DB >> 9591731

Oncocytic adrenocortical neoplasms: a report of seven cases and review of the literature.

B T Lin1, S M Bonsib, G W Mierau, L M Weiss, L J Medeiros.   

Abstract

Oncocytic neoplasms of the adrenal gland are rare. We describe the clinicopathologic and immunohistochemical findings of seven oncocytic adrenocortical neoplasms, five oncocytomas, and two oncocytic neoplasms of uncertain malignant potential. Three tumors were studied using electron microscopy. These neoplasms occurred in five women and two men (median age, 55 years) with no clinical evidence that the neoplasms were functional. The size of the neoplasms varied from 5.0 cm to 13.5 cm. Histologically, each neoplasm was composed exclusively of oncocytes. The oncocytomas had very low or absent mitotic activity and no evidence of necrosis. The two oncocytic neoplasms of uncertain malignant potential had increased mitotic activity and necrosis but no evidence of invasion or metastases. Nuclear atypia, either focal or generalized, was found in all neoplasms. Immunohistochemical studies performed using fixed, paraffin-embedded sections showed strong reactivity with the mitochondrial antibody mES-13 in all neoplasms. Four of five oncocytomas and one oncocytic neoplasm of uncertain malignant potential expressed keratin, predominantly keratin 18, as shown using the CAM 5.2 and AE3 antibodies. Two neuroendocrine-associated markers, neuron specific enolase and synaptophysin, were positive in seven and five neoplasms, respectively. However, all neoplasms were negative for the other neuroendocrine markers tested, including chromogranin A, tyrosine hydroxylase, and dopamine beta-hydroxylase, as well as for epithelial membrane antigen, S100, and p53. Using the MIB-1 (Ki-67) antibody, proliferative activity was increased in both oncocytic neoplasms of uncertain malignant potential. All six patients with available clinical follow-up data are alive without evidence disease, although the follow-up interval is relatively short (< 2 years) for the two patients with oncocytic neoplasms of uncertain malignant potential. We conclude that oncocytic adrenocortical neoplasms are nonfunctional tumors that can become large before they are detected by radiologic studies. The majority of neoplasms are benign and should not be misdiagnosed as carcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591731     DOI: 10.1097/00000478-199805000-00012

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  28 in total

1.  Bilateral adrenocortical oncocytoma with bilateral myelolipomatous metaplasia.

Authors:  Charu Shastri; Chanchal Rana; Niraj Kumari; Gaurav Agarwal; Narendra Krishnani
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

Review 2.  A diagnostic approach to adrenal cortical lesions.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

3.  [Not Available].

Authors:  Hellara Wadia; Lefi Mouni; Touffahi Mounir; Njim Leila; Farhane Samira; Saidi Radhia; Saad Hamadi
Journal:  Can Urol Assoc J       Date:  2008-12       Impact factor: 1.862

Review 4.  Recurrent spindle cell oncocytoma of the pituitary, a case report and review of literature.

Authors:  Yared N Demssie; Jacob Joseph; Timothy Dawson; Gareth Roberts; John de Carpentier; Simon Howell
Journal:  Pituitary       Date:  2011-12       Impact factor: 4.107

Review 5.  Adrenocortical carcinoma.

Authors:  Tobias Else; Alex C Kim; Aaron Sabolch; Victoria M Raymond; Asha Kandathil; Elaine M Caoili; Shruti Jolly; Barbra S Miller; Thomas J Giordano; Gary D Hammer
Journal:  Endocr Rev       Date:  2013-12-20       Impact factor: 19.871

6.  Adrenocortical oncocytoma.

Authors:  P A Kitching; V Patel; H R Harach
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

Review 7.  Functioning adrenocortical oncocytoma: the first documented case producing interleukin-6 and review of the literature.

Authors:  T Akatsu; K Kameyama; K Araki; T Ashizawa; G Wakabayashi; M Kitajima
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

8.  Subclinical Cushing's syndrome associated with an adrenocortical oncocytoma.

Authors:  S S Lee; K H Baek; Y S Lee; J M Lee; M I Kang; B Y Cha; K W Lee; H Y Son; S K Kang
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

9.  Adrenal oncocytic neoplasm with uncertain malignant potential.

Authors:  Mooyad A Ahmed; K S Sureshkannan; Zaid R Raouf; Sreedharan V Koliyadan; Christopher S Grant; Ahmed H Al-Habsi; P A M Saparamadu; Dhuha Al-Sajee
Journal:  Sultan Qaboos Univ Med J       Date:  2013-05-09

10.  Adrenocortical oncocytic carcinoma with recurrent metastases: a case report and review of the literature.

Authors:  Pinelopi Argyriou; Charalambos Zisis; Nektarios Alevizopoulos; Emmanuel M Kefaloyannis; Constantine Gennatas; Constantina D Petraki
Journal:  World J Surg Oncol       Date:  2008-12-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.